[16] CGM has been shown to optimize insulin therapy with favorable effects in BMI and pulmonary function. [17] However, few studies have investigated CGM in CFRD patients on CFTR modulator therapy. [18], [19]. Here, INS is linked to cystic fibrosis-related diabetes.